J
José Cervera
Researcher at Carlos III Health Institute
Publications - 168
Citations - 5653
José Cervera is an academic researcher from Carlos III Health Institute. The author has contributed to research in topics: Myeloid leukemia & Leukemia. The author has an hindex of 35, co-authored 150 publications receiving 5064 citations. Previous affiliations of José Cervera include Laboratory of Molecular Biology & Hospital Universitari i Politècnic La Fe.
Papers
More filters
Journal ArticleDOI
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz,Heinz Tüchler,Francesc Solé,Mar Mallo,E. Luño,José Cervera,Isabel Granada,Barbara Hildebrandt,Marilyn L. Slovak,Kazuma Ohyashiki,Christian Steidl,Christa Fonatsch,Michael Pfeilstöcker,Thomas Nösslinger,Peter Valent,Aristoteles Giagounidis,Carlo Aul,Michael Lübbert,Reinhard Stauder,Otto Krieger,Guillermo Garcia-Manero,Stefan Faderl,Sherry Pierce,Michelle M. Le Beau,John M. Bennett,Peter L. Greenberg,Ulrich Germing,Detlef Haase +27 more
TL;DR: A new and comprehensive cytogenetic scoring system based on an international data collection of 2,902 patients with primary MDS and oligoblastic acute myeloid leukemia (AML) after MDS treated with supportive care only is proposed, providing clear prognostic classification in 91% of all patients.
Journal ArticleDOI
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
Esperanza Such,Ulrich Germing,Luca Malcovati,José Cervera,Andrea Kuendgen,Matteo G. Della Porta,Benet Nomdedeu,Leonor Arenillas,Elisa Luño,Blanca Xicoy,Mari Luz Amigo,David Valcárcel,Kathrin Nachtkamp,Ilaria Ambaglio,Barbara Hildebrandt,Ignacio Lorenzo,Mario Cazzola,Guillermo Sanz +17 more
TL;DR: The prognostic impact of FAB and WHO subtypes are confirmed, the importance of RBC transfusion dependency and cytogenetics is recognized, and a simple and powerful CPSS is offered for accurately assessing prognosis and planning therapy in patients with CMML.
Journal ArticleDOI
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica.
Francesc Solé,Blanca Espinet,Guillermo Sanz,José Cervera,Maria-Jose Calasanz,Elisa Luño,F. Prieto,Isabel Granada,J M Hernández,Cigudosa Jc,J.L. Diez,E Bureo,M L Marqués,E. Arranz,Rafael Rios,J A Martinez Climent,Teresa Vallespi,Lourdes Florensa,Soledad Woessner +18 more
TL;DR: In this paper, a consensus International Prognostic Scoring System (IPSS) for predicting outcome and planning therapy in the myelodysplastic syndromes (MDS) has been developed.
Journal ArticleDOI
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Esperanza Such,José Cervera,Dolors Costa,Francesc Solé,Teresa Vallespi,Elisa Luño,Rosa Collado,María José Calasanz,Jesús M. Hernández-Rivas,Juan C. Cigudosa,Benet Nomdedeu,Mar Mallo,Felix Carbonell,Javier Bueno,María Teresa Ardanaz,Fernando Ramos,Mar Tormo,Reyes Sancho-Tello,Consuelo del Cañizo,Valle Gomez,Victor Marco,Blanca Xicoy,Santiago Bonanad,Carmen Pedro,Teresa Bernal,Guillermo Sanz +25 more
TL;DR: Cytogenetic findings have a strong prognostic impact in patients with chronic myelomonocytic leukemia and were confirmed as an independent prognostic variable for overall survival on univariate and multivariate analysis.
Journal ArticleDOI
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.
Guillermo Sanz,S Saavedra,Dolores Planelles,Leonor Senent,José Cervera,Eva Barragán,C Jiménez,Luis Larrea,Guillermo Martin,Jesús Martínez,Isidro Jarque,Federico Moscardó,G Plumé,Rafael Andreu,Ana I. Regadera,Inmaculada Garcı́a,S Molla,Pilar Solves,Javier de la Rubia,Pascual Bolufer,Luis Benlloch,Soler Ma,María L. Marty,Miguel A. Sanz +23 more
TL;DR: Preliminary results suggest that UD-CBT should be considered a reasonable alternative in young adults with hematologic malignancy and no appropriate bone marrow donor.